Abstract
Topical corticosteroids (TCS) are readily available and widely used in Australia. Low and moderate potency TCS may be purchased over the counter. Potent TCS are commonly prescribed in all age groups and have recently become easier to prescribe in large quantities. Australian TCS guidelines focus on TCS safety and under-treatment (‘steroid phobia’). However, reported cases of ‘steroid withdrawal syndrome’ indicate TCS overuse exists in Australia too.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Britt H, Miler GC, Bayram C, Henderson J, et al. A decade of Australian general practice 2006–2007 to 2015–2016, General Practice Series Number 41. Sydney: Family Medicine Research Centre. The University of Sydney; 2016.
Smith SD, Lee A, Blaszczynski A, Fischer G. An assessment of Australian general practitioners’ knowledge about use of topical corticosteroids in paediatric atopic dermatitis. Aust J Dermatol. 2016;57:17–8.
Smith S, Lee A, Blaszczynski A, Fisher G. Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in paediatric atopic dermatitis. Aust J Dermatol. 2016;57:278–83. doi:10.1111/ajd.12402.
Topical issues—emollients and corticosteroids. Nov 2012. Australian Government Department of Veterans’ Affairs www.veteransmates.net.au/topic-33-therapeutic-brief. Accessed 12 March 2017.
Mooney E, Rademaker M, Dailey R, Daniel BS, et al. Adverse effects of topical corticosteroids in paediatric eczema: Australian consensus statement. Aust J Dermatol. 2015;56(4):241–51.
Carlos G, Uribe P. Fernandez-Penas rational use of topical corticosteroids. Aust Prescr. 2013;36:5–6. doi:10.18773/austprescr.2013.063.
Dermatology Therapeutic Guidelines eTG. November 2016. Website: www.tg.org.au. Accessed 12 March 2017.
Smith SD, Dixit S, Fischer G. Childhood atopic dermatitis overcoming parental topical corticosteroid phobia. Med Today. 2013;14(6):47–52.
Smith SD, Stephens AM, Werren JC, Fischer GO. Treatment failure in atopic dermatitis as a result of parental health belief. MJA. 2013;199(7):467–9.
Smith SD, Lee A, Blaszczynski A, Fischer G. Pharmacists’ knowledge about use of topical corticosteroids in atopic dermatitis: pre and post continuing professional development education. Aust J Dermatol. 2015;5:199–204. doi:10.1111/ajd.12339.
Smith SD, Hong E, Feams S, et al. Corticosteroid phobia and other cofounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Aust J Dermatol. 2010;51(3):168–74.
Sheary B. Topical corticosteroid addiction and withdrawal in a 6 year old. J Prim Health Care. 2017; doi:10.1071/HC16049.
https://www.tga.gov.au/reporting-adverse-events. Accessed 12 March 2017.
Sheary B. Topical corticosteroid addiction and withdrawal—an overview for GPs. Aust Fam Physician. 2016;45(6):386–8.
Saxon S, Fischer G. Childhood atopic dermatitis: exploring the safety, efficacy and potential misinformation around topical corticosteroids. Australas J Pharm. 2016;97(1155):83–8.
Carter S. Topical steroids on old dry skin. Aust Pharm. 2016;35(8):20–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sheary, B. (2018). Topical Corticosteroid Use and Overuse: An Australian Perspective. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_24
Download citation
DOI: https://doi.org/10.1007/978-981-10-4609-4_24
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4608-7
Online ISBN: 978-981-10-4609-4
eBook Packages: MedicineMedicine (R0)